Autoantibodies in moderate and critical cases of COVID‐19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autoantibodies in moderate and critical cases of COVID‐19

Published:2021-05-02 Issue:5 Volume:14 Page:1625-1626
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Chang Soon Hee¹^ORCID,Minn Dohsik²^ORCID,Kim Yu Kyung¹^ORCID

Affiliation:

1. Department of Clinical Pathology School of Medicine Kyungpook National University Daegu Korea

2. Department of Diagnostic Immunology Seegene Medical Foundation Seoul Korea

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13036

Reference5 articles.

1. COVID‐19 and Immunological Dysregulation: Can Autoantibodies be Useful?

2. A Brief Telephone Severity Scoring System and Therapeutic Living Centers Solved Acute Hospital-Bed Shortage during the COVID-19 Outbreak in Daegu, Korea

3. SARS‐CoV‐2 infection as a trigger of autoimmune response;Sacchi MC;Clin Transl Sci

4. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19

5. The correlation between SARS-CoV-2 infection and rheumatic disease

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study;Biomedicines;2024-06-13

2. Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review;American Journal of Medicine Open;2024-06

3. Mild‐to‐moderate COVID‐19 does not predispose to the development of autoimmune rheumatic diseases or autoimmune‐based thrombosis;Scandinavian Journal of Immunology;2023-07-26

4. Is COVID-19 severity unrelated to antinuclear antibodies?;Transplant Immunology;2023-06

5. Clinical significance of antinuclear antibody positivity in patients with severe coronavirus disease 2019;The Korean Journal of Internal Medicine;2023-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3